English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduNew research from the UC Davis School of Medicine shows high blood pressure in early adulthood is associated with worse brain health in late life — especially for men. The results suggest that treating hypertension in young and middle-aged adults may help prevent dementia and Alzheimer’s disease.
Tag: Alzheimer’s disease research
Rutgers to Open Alzheimer’s and Dementia Clinical Research and Treatment Center
Rutgers Biomedical and Health Sciences (RBHS) is launching the Herbert and Jacqueline Krieger Klein Alzheimer’s and Dementia Clinical Research and Treatment Center. Based at the Rutgers Brain Health Institute and scheduled to open in fall 2023, the center will offer research expertise from the institute, Rutgers Robert Wood Johnson Medical School, Rutgers New Jersey Medical School and the Rutgers Institute for Health, Health Care Policy and Aging Research as well as facilitate clinical research in Alzheimer’s disease that could result in new medical treatments.
MIND Diet Linked to Better Cognitive Performance
Researchers at Rush University Medical Center have found that older adults may benefit from a specific diet called the MIND diet even when they develop these protein deposits, known as amyloid plaques and tangles.
Neuroscience scholarship dedicated to golf journalist Tim Rosaforte ’77
The University of Rhode Island has established an endowed scholarship for undergraduates in the field of neuroscience. The scholarship is named in honor of James Tim Rosaforte III ’77, an accomplished sports journalist and author well known in the world of professional golf. Rosaforte retired last year after being diagnosed with Alzheimer’s Disease, following a distinguished 40-year career in newspapers and television.
Renowned Alzheimer’s Clinical Trials Researcher Available to Comment on June 7 FDA Approval of Aducanumab
The Food and Drug Administration on June 7 approved Aducanumab, which will carry the brand name Aduhelm, as the first new treatment for Alzheimer’s disease in nearly 20 years. Dr. Jeffrey L. Cummings, UNLV research professor and leading expert on Alzheimer’s clinical trials, calls…
Us Against Alzheimer’s advocacy group must reveal financial conflict of interest to FDA, says Dr. Leslie Norins of Alzheimer’s Germ Quest
Alzheimer’s advocacy groups taint their credibility by not revealing conflicts when they lobby FDA for drug approval
Curcumin Selected as Cognition Supplement of the Year: 2021, says Dr. Leslie Norins of MCI911.com
As yet there is no prescription drug to cure mild cognitive impairment (MCI), often a harbinger of Alzheimer’s disease. Medical research journals reveal curcumin can sometimes bolster cognition. It merits a try.
Mount Sinai Researchers Identify Protein that Protects Against Alzheimer’s Disease
Detailed predictive analyses and functional studies show that the VGF protein protects against onset and progression of Alzheimer’s disease, paving the way for future drug discovery efforts
The Human Brain’s Meticulous Interface with the Bloodstream now on a Precision Chip
It can be the bain of brain drug developers: The interface between the human brain and the bloodstream, the blood-brain-barrier, is so meticulous that animal models often fail to represent it. This improved chip represents important features more accurately.
Investigational drugs didn’t slow memory loss, cognitive decline in rare, inherited Alzheimer’s, initial analysis indicates
Top-line data reported from international trial
Flickering Light Mobilizes Brain Chemistry That May Fight Alzheimer’s
The promise of flickering light to treat Alzheimer’s takes another step forward in this new study, which reveals stark biochemical mechanisms: The 40 Hertz stimulation triggers a marked release of signaling chemicals.
Kim Campbell, Alzheimer’s disease advocate and widow of music legend Glen Campbell, to keynote ANA2019 October 13
WHO: Kim Campbell, Alzheimer’s disease advocate and widow of Grammy Hall of Fame and Award-winning music legend Glen Campbell; and ANA President David Holtzman, MD, ANA President, Professor and Chairman of the Department of Neurology at the Washington University School…